300015 爱尔眼科
已收盘 03-20 15:00:00
资讯
新帖
简况
爱尔眼科：新十年聚焦高质量发展
证券之星 · 03-19 17:21
爱尔眼科：新十年聚焦高质量发展
爱尔眼科：公司逐步向“前沿科技+眼科医院”的平台型医疗机构升级
证券日报 · 03-18 20:38
爱尔眼科：公司逐步向“前沿科技+眼科医院”的平台型医疗机构升级
爱尔眼科：大成基金、国泰海通证券等多家机构于3月17日调研我司
证券之星 · 03-18 19:01
爱尔眼科：大成基金、国泰海通证券等多家机构于3月17日调研我司
爱尔眼科（300015）披露控股股东部分股份解除质押公告，3月16日股价上涨1.28%
证券之星 · 03-16
爱尔眼科（300015）披露控股股东部分股份解除质押公告，3月16日股价上涨1.28%
股市必读：爱尔眼科（300015）3月11日董秘有最新回复
证券之星 · 03-12
股市必读：爱尔眼科（300015）3月11日董秘有最新回复
新股消息 | 计划赴港上市？爱尔眼科(300015.SZ)回应：以公告信息为准
智通财经 · 03-09
新股消息 | 计划赴港上市？爱尔眼科(300015.SZ)回应：以公告信息为准
爱尔眼科：油价变化与眼科耗材相关度极低
证券之星 · 03-06
爱尔眼科：油价变化与眼科耗材相关度极低
爱尔眼科：成本控制与增长潜力，预测一季度净利润12.12亿元，同比变动15.5%
朝阳永续 · 03-03
爱尔眼科：成本控制与增长潜力，预测一季度净利润12.12亿元，同比变动15.5%
爱尔眼科：成立多学科合作的老视学组
证券之星 · 03-02
爱尔眼科：成立多学科合作的老视学组
巴伐利亚眼科全年净利润达4210万欧元
投资观察 · 02-28
巴伐利亚眼科全年净利润达4210万欧元
爱尔眼科：2025年度经营正常，将于2026年4月24日按时披露年度报告
证券之星 · 02-26
爱尔眼科：2025年度经营正常，将于2026年4月24日按时披露年度报告
爱尔眼科：截至2025年9月30日，公司股东总数为344,788户
证券之星 · 02-14
爱尔眼科：截至2025年9月30日，公司股东总数为344,788户
股市必读：爱尔眼科（300015）2月11日董秘有最新回复
证券之星 · 02-12
股市必读：爱尔眼科（300015）2月11日董秘有最新回复
爱尔眼科：公司基于现阶段的发展战略和广大股东的长远利益合理规划使用资金（含理财），以增加公司收益
证券之星 · 02-11
爱尔眼科：公司基于现阶段的发展战略和广大股东的长远利益合理规划使用资金（含理财），以增加公司收益
爱尔眼科：公司坚持合规经营，致力于高质量发展
证券之星 · 02-10
爱尔眼科：公司坚持合规经营，致力于高质量发展
爱尔眼科：如有进一步回购计划将按规定披露
证券之星 · 02-10
爱尔眼科：如有进一步回购计划将按规定披露
爱尔眼科跌3% 未正面回应陈邦是否”骗保”医院实控人
中金财经 · 02-09
爱尔眼科跌3% 未正面回应陈邦是否”骗保”医院实控人
爱尔眼科：不属实，董秘刚刚参加了董事长主持的会议
证券之星 · 02-09
爱尔眼科：不属实，董秘刚刚参加了董事长主持的会议
爱尔眼科陈邦的精神病院王国“不精神”
蓝鲸财经 · 02-09
爱尔眼科陈邦的精神病院王国“不精神”
网传文件指关联襄阳民营医院 爱尔眼科紧急辟谣称“从未参与”
新浪证券 · 02-06
网传文件指关联襄阳民营医院 爱尔眼科紧急辟谣称“从未参与”
加载更多
公司概况
公司名称：
爱尔眼科医院集团股份有限公司
所属行业：
卫生
上市日期：
2009-10-30
主营业务：
爱尔眼科医院集团股份有限公司的主营业务是各类眼科疾病诊疗、手术服务与医学验光配镜服务。公司的主要产品是屈光项目、白内障项目、眼前段项目、眼后段项目、视光服务项目。
发行价格：
28.00
{"stockData":{"symbol":"300015","market":"SZ","secType":"STK","nameCN":"爱尔眼科","latestPrice":9.98,"timestamp":1773990210000,"preClose":10.11,"halted":0,"volume":51303539,"delay":0,"changeRate":-0.0129,"floatShares":7955000000,"shares":9325000000,"eps":0.3452,"marketStatus":"已收盘","change":-0.13,"latestTime":"03-20 15:00:00","open":10.1,"high":10.15,"low":9.95,"amount":515000000,"amplitude":0.0198,"askPrice":9.98,"askSize":1434,"bidPrice":9.97,"bidSize":638,"shortable":0,"etf":0,"ttmEps":0.3452,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":5,"adr":0,"adjPreClose":10.11,"symbolType":"stock","openAndCloseTimeList":[[1773970200000,1773977400000],[1773982800000,1773990000000]],"highLimit":11.12,"lowLimit":9.1,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":9325396670,"isCdr":false,"pbRate":4.2,"roa":"--","peRate":28.910776,"roe":"14.32%","epsLYR":0.3847,"committee":0.192079,"marketValue":93067000000,"turnoverRate":0.0064,"status":1,"floatMarketCap":79394000000},"requestUrl":"/m/hq/s/300015","defaultTab":"news","newsList":[{"id":"2620924538","title":"爱尔眼科：新十年聚焦高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2620924538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620924538?lang=zh_cn&edition=full","pubTime":"2026-03-19 17:21","pubTimestamp":1773912067,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科03月19日在投资者关系平台上答复投资者关心的问题。公司前十年通过内涵增长、外延扩张双轮驱动，快速完善网络布局，实现业绩稳步增长，服务网络已覆盖大多数城乡县域。新十年，公司聚焦高质量发展，持续推进“1+8+N”战略，进一步提升核心业务，优化区域医疗资源，加快数字化赋能，强化医疗能力和内在价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900028146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300015","BK0028","BK0113","LU1820825898.SGD","BK0012","BK0196","BK0236","BK0114","LU0979878070.USD","LU1146622755.USD","BK0188","LU1242518857.USD","LU1242518931.SGD","BK0096","BK0200"],"gpt_icon":0},{"id":"2620675256","title":"爱尔眼科：公司逐步向“前沿科技+眼科医院”的平台型医疗机构升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2620675256","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620675256?lang=zh_cn&edition=full","pubTime":"2026-03-18 20:38","pubTimestamp":1773837480,"startTime":"0","endTime":"0","summary":"证券日报网3月18日讯 ，爱尔眼科在接受调研者提问时表示，科技进步是推动医疗行业发展的重要驱动力。公司几年前已与科研机构合作成立数字眼科实验室，探索人工智能、大数据在眼病筛查、辅助诊断及医疗流程优化等场景中的应用，逐步向“前沿科技+眼科医院”的平台型医疗机构升级。公司的核心定位始终是以医疗服务为主的医院集团，是直接面向患者的重要服务入口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-18/doc-inhrmihr9322582.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-18/doc-inhrmihr9322582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300015","BK0200","LU1820825898.SGD","BK0113","LU1242518857.USD","BK0077","LU0979878070.USD","BK0096","BK0028","BK0188","BK0114","BK0236","BK0012","BK0196","LU1146622755.USD","LU1242518931.SGD"],"gpt_icon":0},{"id":"2620189237","title":"爱尔眼科：大成基金、国泰海通证券等多家机构于3月17日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2620189237","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620189237?lang=zh_cn&edition=full","pubTime":"2026-03-18 19:01","pubTimestamp":1773831675,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年3月18日爱尔眼科发布公告称大成基金戴军 陈泉龙 李博 侯春燕 杨挺 邹建 赵蓬 王晶晶、国泰海通证券陈铭 张澄于2026年3月17日调研我司。目前，公司海外业务收入占比约 13%左右，未来有望进一步突破。爱尔眼科主营业务：主要从事各类眼科疾病诊疗、手术服务与医学验光配镜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800033715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0200","BK0028","LU1820825898.SGD","BK0236","BK0188","LU1242518857.USD","BK0012","300015","601211","BK0184","BK0096","LU0979878070.USD","LU1146622755.USD","BK0201","BK0276","BK0113","BK0196","BK0114","LU1242518931.SGD","BK1147","161027","BK1564","BK0183","02611","BK0077"],"gpt_icon":0},{"id":"2619461882","title":"爱尔眼科（300015）披露控股股东部分股份解除质押公告，3月16日股价上涨1.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619461882","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619461882?lang=zh_cn&edition=full","pubTime":"2026-03-16 22:13","pubTimestamp":1773670399,"startTime":"0","endTime":"0","summary":"截至2026年3月16日收盘，爱尔眼科报收于10.29元，较前一交易日上涨1.28%，最新总市值为959.58亿元。爱尔眼科医院集团股份有限公司于2026年3月16日发布公告，公司控股股东爱尔医疗投资集团有限公司将其持有的109,494,149股公司股份解除质押，占其所持股份比例3.42%，占公司总股本比例1.17%，质押起始日为2020年12月21日，解除日期为2026年3月13日，质权人为深圳平安汇通投资管理有限公司。本次解除质押后，爱尔医疗投资累计质押股份为611,241,045股，占其持股比例19.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600036348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","300015","BK0096","BK0236","BK0113","BK0114","LU1820825898.SGD","BK0077","LU1242518857.USD","BK0200","BK0188","BK0196","LU0979878070.USD","LU1242518931.SGD","LU1146622755.USD","BK0028"],"gpt_icon":0},{"id":"2618313922","title":"股市必读：爱尔眼科（300015）3月11日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2618313922","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618313922?lang=zh_cn&edition=full","pubTime":"2026-03-12 01:04","pubTimestamp":1773248654,"startTime":"0","endTime":"0","summary":"截至2026年3月11日收盘，爱尔眼科报收于10.29元，下跌0.48%，换手率0.56%，成交量44.38万手，成交额4.57亿元。董秘最新回复投资者： 传出公司要去香港上市，就目前的市值来说，上h后市值港股估值打5折的不是没这个可能，请问公司出现这个情况，如何维护A股的权益？重大信息以公司公告为准。当日关注点来自交易信息汇总：3月11日主力资金净流入1380.88万元，显示主力对爱尔眼科的积极布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200000731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0200","BK0012","BK0114","BK0113","LU1242518931.SGD","LU0979878070.USD","BK0096","BK0077","BK0236","BK0196","LU1242518857.USD","LU1820825898.SGD","BK0188","BK0028","LU1146622755.USD","300015"],"gpt_icon":0},{"id":"2618643752","title":"新股消息 | 计划赴港上市？爱尔眼科(300015.SZ)回应：以公告信息为准","url":"https://stock-news.laohu8.com/highlight/detail?id=2618643752","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618643752?lang=zh_cn&edition=full","pubTime":"2026-03-09 15:52","pubTimestamp":1773042746,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月9日，据媒体报道，爱尔眼科(300015.SZ)正计划赴港上市。知情人士透露，这家中国最大的眼科连锁医院正在与顾问合作筹备股份出售事宜。IPO规模和时间等细节仍在商讨中。对此，爱尔眼科方面回应，以公告信息为准，重大事项都会发布公告。据其官网显示，爱尔眼科成立于2002年，并于2009年在深圳上市，截至2023年底，旗下运营着近900家眼科医院、眼科中心和诊所。其中大部分位于中国内地，此外在欧洲、东南亚和中国香港也设有诊所。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411573.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1242518931.SGD","BK0113","BK0196","LU1146622755.USD","BK0028","BK0114","BK0200","BK0188","BK0096","LU1820825898.SGD","LU1242518857.USD","300015","BK0077","BK0236","BK0012","LU0979878070.USD"],"gpt_icon":0},{"id":"2617440683","title":"爱尔眼科：油价变化与眼科耗材相关度极低","url":"https://stock-news.laohu8.com/highlight/detail?id=2617440683","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617440683?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:36","pubTimestamp":1772786170,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)03月06日在投资者关系平台上答复投资者关心的问题。投资者提问：你好董秘，请问石油涨价，对贵司的医疗耗材成本影响大吗？爱尔眼科回复：谢谢您对公司的关注。万物皆有联系，但油价变化与眼科耗材相关度极低。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600026333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0236","LU0979878070.USD","BK0077","BK0114","BK0200","LU1820825898.SGD","BK0028","BK0012","300015","LU1146622755.USD","BK0096","BK0113","LU1242518857.USD","LU1242518931.SGD","BK0188"],"gpt_icon":0},{"id":"2616346704","title":"爱尔眼科：成本控制与增长潜力，预测一季度净利润12.12亿元，同比变动15.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616346704","media":"朝阳永续","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616346704?lang=zh_cn&edition=full","pubTime":"2026-03-03 17:39","pubTimestamp":1772530740,"startTime":"0","endTime":"0","summary":"管理层预计2026年收入增长将达到中位数，其中屈光和验光业务增长超过15%，白内障手术可能稍低。分业务来说：1) DRG/DIP和成本控制：爱尔眼科通过提高效率、优化病例组合和利用规模优势，成功抵消了潜在的价格压力，上海DRG试点医院在实施的头两年均实现了预算盈余。尽管宏观经济疲软导致全国屈光手术需求增长放缓，但公司通过技术升级和新程序采用，继续扩大市场份额，商业保险收入增长超过20%，为收入增长提供支持。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-03/doc-inhpteii0768787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300015"],"gpt_icon":0},{"id":"2616857973","title":"爱尔眼科：成立多学科合作的老视学组","url":"https://stock-news.laohu8.com/highlight/detail?id=2616857973","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616857973?lang=zh_cn&edition=full","pubTime":"2026-03-02 15:31","pubTimestamp":1772436660,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科03月02日在投资者关系平台上答复投资者关心的问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200015683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0200","BK0077","BK0188","LU0979878070.USD","LU1242518931.SGD","LU1242518857.USD","BK0236","BK0114","LU1146622755.USD","BK0113","BK0196","BK0028","LU1820825898.SGD","BK0012","BK0096","300015"],"gpt_icon":0},{"id":"1158917709","title":"巴伐利亚眼科全年净利润达4210万欧元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158917709","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158917709?lang=zh_cn&edition=full","pubTime":"2026-02-28 00:53","pubTimestamp":1772211200,"startTime":"0","endTime":"0","summary":"2月27日（路透社）—— 巴伐利亚诊所股份有限公司公布全年财务数据：*全年净利润为4210万欧元*全年营业收入达3.081亿欧元*全年税息折旧及摊销前利润（EBITDA）为8450万欧元。数据来源时间：2026年2月27日16:31:25.947 GMT","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300015","BK0200","LU1242518931.SGD","BK0188","LU1820825898.SGD","BK0012","BK0113","BK0236","BK0096","LU1242518857.USD","BK0077","BK0114","LU1146622755.USD","BK0196","BK0028","LU0979878070.USD"],"gpt_icon":0},{"id":"2614155410","title":"爱尔眼科：2025年度经营正常，将于2026年4月24日按时披露年度报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2614155410","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614155410?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:57","pubTimestamp":1772096227,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)02月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，公司去年年末没有发布业绩预告，近期会发布业绩快报吗。爱尔眼科回复：谢谢您对公司的关注。根据《深圳证券交易所创业板股票上市规则（2024 年修订）》6.2.2款规定，公司无需发布业绩预告。2025年度经营正常，将于2026年4月24日按时披露年度报告。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600024856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","LU1820825898.SGD","LU1146622755.USD","BK0012","BK0028","BK0077","300015","BK0113","BK0188","BK0200","BK0114","BK0196","LU1242518931.SGD","LU1242518857.USD","BK0096","LU0979878070.USD"],"gpt_icon":0},{"id":"2611194798","title":"爱尔眼科：截至2025年9月30日，公司股东总数为344,788户","url":"https://stock-news.laohu8.com/highlight/detail?id=2611194798","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611194798?lang=zh_cn&edition=full","pubTime":"2026-02-14 09:03","pubTimestamp":1771030989,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)02月14日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，截止2026.2.13最新股东人数多少了?爱尔眼科回复：谢谢您对公司的关注! 公司按照有关法律法规履行信息披露义务，截至2025年9月30日，公司股东总数为344,788户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021400004958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","BK0096","BK0012","BK0188","LU1242518931.SGD","BK0200","300015","LU1146622755.USD","LU1242518857.USD","BK0028","BK0196","BK0113","BK0236","LU0979878070.USD","BK0077","BK0114"],"gpt_icon":0},{"id":"2610579679","title":"股市必读：爱尔眼科（300015）2月11日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2610579679","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610579679?lang=zh_cn&edition=full","pubTime":"2026-02-12 00:48","pubTimestamp":1770828495,"startTime":"0","endTime":"0","summary":"截至2026年2月11日收盘，爱尔眼科报收于10.72元，上涨0.19%，换手率0.78%，成交量61.76万手，成交额6.63亿元。目前有关部门对襄阳恒泰康尚无调查结论，请勿轻信网络信息。后续如有进一步回购计划，将及时对外披露。投资者： 我是贵公司股东，截止到2026年2月6号公司股东人数请董秘及时告知？公司按照有关法律法规履行信息披露义务，截至2025年9月30日，公司股东总数为344,788户。公司已于2月6日发布的《澄清公告》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200001094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","BK0188","BK0200","BK0028","BK0077","BK0196","BK0236","LU1146622755.USD","BK0096","LU1242518931.SGD","BK0114","LU0979878070.USD","LU1242518857.USD","300015","BK0012","BK0113"],"gpt_icon":0},{"id":"2610937285","title":"爱尔眼科：公司基于现阶段的发展战略和广大股东的长远利益合理规划使用资金（含理财），以增加公司收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2610937285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610937285?lang=zh_cn&edition=full","pubTime":"2026-02-11 20:52","pubTimestamp":1770814377,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科02月11日在投资者关系平台上答复投资者关心的问题。而贵公司还在指数两千八左右的位置，近期又被各种抹黑，建议公司拿出部分理财的钱进行回购！公司持续加强市场沟通，通过线上、线下多渠道传递行业和公司发展情况。公司基于现阶段的发展战略和广大股东的长远利益合理规划使用资金（含理财），以增加公司收益。后续如有进一步回购计划，将及时对外披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100036312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0113","BK0200","BK0236","300015","BK0188","LU1146622755.USD","BK0012","LU0979878070.USD","BK0114","LU1242518857.USD","LU1242518931.SGD","BK0077","LU1820825898.SGD","BK0028","BK0096"],"gpt_icon":0},{"id":"2610864045","title":"爱尔眼科：公司坚持合规经营，致力于高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2610864045","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610864045?lang=zh_cn&edition=full","pubTime":"2026-02-10 20:48","pubTimestamp":1770727703,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)02月09日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司如何看待并应对此次危机事件，如何看待公司目前的估值，如果认为是躺枪，为啥不采取回购或增持措施。爱尔眼科回复：谢谢关注。公司坚持合规经营，致力于高质量发展，此前已多次进行回购或增持，如有进一步计划，将按相关规定信息披露。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021000036659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0012","BK0200","BK0096","LU1242518857.USD","LU1820825898.SGD","BK0236","LU1146622755.USD","BK0113","BK0188","LU0979878070.USD","BK0028","BK0077","LU1242518931.SGD","300015","BK0196"],"gpt_icon":0},{"id":"2610640430","title":"爱尔眼科：如有进一步回购计划将按规定披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2610640430","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610640430?lang=zh_cn&edition=full","pubTime":"2026-02-10 20:48","pubTimestamp":1770727703,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)02月09日在投资者关系平台上答复投资者关心的问题。投资者提问：公司领导什么时候回购股票！！！爱尔眼科回复：谢谢关注。公司基于现阶段的发展战略和广大股东的长远利益合理规划使用资金，如有进一步回购计划，将按照相关规定对外披露。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021000036660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0200","BK0012","BK0114","BK0113","LU1242518931.SGD","LU0979878070.USD","BK0096","BK0077","BK0236","BK0196","LU1242518857.USD","LU1820825898.SGD","BK0188","BK0028","LU1146622755.USD","300015"],"gpt_icon":0},{"id":"2610635274","title":"爱尔眼科跌3% 未正面回应陈邦是否”骗保”医院实控人","url":"https://stock-news.laohu8.com/highlight/detail?id=2610635274","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610635274?lang=zh_cn&edition=full","pubTime":"2026-02-09 17:45","pubTimestamp":1770630307,"startTime":"0","endTime":"0","summary":"中国经济网北京2月9日讯 爱尔眼科 今日收报10.74元，跌幅2.98%。爱尔眼科于2月6日回应中新网称，涉事医院并非爱尔眼科上市公司体系内企业，作为投资人之一，陈邦并不直接参与恒泰康的经营管理。 爱尔眼科年报显示，爱尔医疗投资集团有限公司为公司控股股东，陈邦为实际控制人。 爱尔眼科2月6日发布澄清公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260209/32007834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1242518931.SGD","BK0113","BK0196","LU1146622755.USD","BK0028","BK0114","BK0200","BK0188","BK0096","LU1820825898.SGD","LU1242518857.USD","300015","BK0077","BK0236","BK0012","LU0979878070.USD"],"gpt_icon":0},{"id":"2610863820","title":"爱尔眼科：不属实，董秘刚刚参加了董事长主持的会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2610863820","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610863820?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:57","pubTimestamp":1770627427,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科(300015)02月09日在投资者关系平台上答复投资者关心的问题。投资者提问：股吧有传，董事长已被留置，请问是否属实。如不属实，公司是否采取进一步措施？爱尔眼科回复：不属实，董秘刚刚参加了董事长主持的会议。请睁大眼睛甄别网络信息，避免轻信上当。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020900020900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0188","BK0077","300015","BK0196","BK0200","BK0096","BK0236","LU0979878070.USD","LU1242518931.SGD","BK0012","LU1146622755.USD","LU1242518857.USD","BK0028","LU1820825898.SGD","BK0113"],"gpt_icon":0},{"id":"2610507468","title":"爱尔眼科陈邦的精神病院王国“不精神”","url":"https://stock-news.laohu8.com/highlight/detail?id=2610507468","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610507468?lang=zh_cn&edition=full","pubTime":"2026-02-09 11:29","pubTimestamp":1770607776,"startTime":"0","endTime":"0","summary":"陈邦间接控制的一家精神病医院，就是媒体报道中涉嫌骗保的医院之一。尽管，爱尔眼科极力撇清与创始人体外的精神病产业之间的关系，但随着媒体调查的逐渐深入，信任危机已不可避免地波及整个爱尔医疗体系。仅在襄阳市，精神病医院就多达20多家。公开资料显示，除了此次被媒体曝光的襄阳恒泰康医院，湖南恒泰康旗下多家精神病医院，都曾因“套保”被监管部门处罚。其中，南昌爱尔被当地医保局处以罚款77.25万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1770599142680993214","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0028","LU1242518931.SGD","LU1820825898.SGD","300015","LU1146622755.USD","BK0096","BK0200","LU1242518857.USD","BK0012","BK0077","BK0196","BK0114","LU0979878070.USD","BK0113","BK0188","BK0236"],"gpt_icon":0},{"id":"2609698325","title":"网传文件指关联襄阳民营医院 爱尔眼科紧急辟谣称“从未参与”","url":"https://stock-news.laohu8.com/highlight/detail?id=2609698325","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609698325?lang=zh_cn&edition=full","pubTime":"2026-02-06 17:37","pubTimestamp":1770370620,"startTime":"0","endTime":"0","summary":" 近日，一份涉及湖北襄阳某民营医院的文件截图在部分投资者社群及社交平台流传。该文件内容显示，当地有关部门在对襄阳恒泰康医院进行检查时，发现其存在多项管理问题。由于文件中出现“爱尔”字样，市场迅速将其与上市公司爱尔眼科医院集团股份有限公司联系起来，引发投资者对其旗下医院管理合规性的担忧。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-02-06/doc-inhkwnkc8037082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","LU1242518931.SGD","LU1820825898.SGD","300015","LU1146622755.USD","BK0096","09906","BK0200","LU1242518857.USD","BK0012","BK0077","BK0196","BK0114","LU0979878070.USD","BK0113","BK0188","BK0236","BK1209"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773996224334,"stockEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.104},{"period":"6month","weight":-0.1844},{"period":"1year","weight":-0.2739},{"period":"ytd","weight":-0.073}],"compareEarnings":[{"period":"1week","weight":-0.0297},{"period":"1month","weight":-0.0185},{"period":"3month","weight":0.0298},{"period":"6month","weight":0.0488},{"period":"1year","weight":0.1693},{"period":"ytd","weight":0.0095}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"爱尔眼科医院集团股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"344788人(较上一季度增加0.27%)","perCapita":"23073股","listingDate":"2009-10-30","address":"湖南省长沙市天心区芙蓉南路一段188号爱尔大厦","registeredCapital":"932539万元","survey":" 爱尔眼科医院集团股份有限公司的主营业务是各类眼科疾病诊疗、手术服务与医学验光配镜服务。公司的主要产品是屈光项目、白内障项目、眼前段项目、眼后段项目、视光服务项目。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱尔眼科,300015,爱尔眼科股票,爱尔眼科股票老虎,爱尔眼科股票老虎国际,爱尔眼科行情,爱尔眼科股票行情,爱尔眼科股价,爱尔眼科股市,爱尔眼科股票价格,爱尔眼科股票交易,爱尔眼科股票购买,爱尔眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}